Grace Macaulay
@gracemacaulay.bsky.social
Paediatric Specialty Trainee | Researcher | Academic Visitor University of Oxford Department of Paediatrics & Evelina London Children’s Hospital | MB ChB BMedSc(Hons) DCH |
Great to host the London School of Paediatrics Research Evening last week — brilliant to see the research being done by trainees across London. Huge thanks to our speakers, attendees, and team!🔬🩺✨
#londonschoolofpaediatrics #paediatricresearch
#londonschoolofpaediatrics #paediatricresearch
November 27, 2025 at 9:38 AM
Great to host the London School of Paediatrics Research Evening last week — brilliant to see the research being done by trainees across London. Huge thanks to our speakers, attendees, and team!🔬🩺✨
#londonschoolofpaediatrics #paediatricresearch
#londonschoolofpaediatrics #paediatricresearch
Reposted by Grace Macaulay
Oral vaccine protects against Salmonella Paratyphi in human challenge trial
The two-dose oral vaccine had an efficacy of 73% in healthy volunteers who were exposed to Salmonella Paratyphi A, which causes paratyphoid fever.
www.cidrap.umn.edu/s...
The two-dose oral vaccine had an efficacy of 73% in healthy volunteers who were exposed to Salmonella Paratyphi A, which causes paratyphoid fever.
www.cidrap.umn.edu/s...
October 31, 2025 at 7:42 PM
Oral vaccine protects against Salmonella Paratyphi in human challenge trial
The two-dose oral vaccine had an efficacy of 73% in healthy volunteers who were exposed to Salmonella Paratyphi A, which causes paratyphoid fever.
www.cidrap.umn.edu/s...
The two-dose oral vaccine had an efficacy of 73% in healthy volunteers who were exposed to Salmonella Paratyphi A, which causes paratyphoid fever.
www.cidrap.umn.edu/s...
Reposted by Grace Macaulay
In a trial in healthy U.K. adults who were challenged with S. Paratyphi A in a controlled human infection model, two doses of the candidate vaccine CVD 1902 led to protection against S. Paratyphi A infection. Full VASP phase 2b trial results: nej.md/3Lypfd5
#MedSky #IDSky
#MedSky #IDSky
October 31, 2025 at 1:02 PM
In a trial in healthy U.K. adults who were challenged with S. Paratyphi A in a controlled human infection model, two doses of the candidate vaccine CVD 1902 led to protection against S. Paratyphi A infection. Full VASP phase 2b trial results: nej.md/3Lypfd5
#MedSky #IDSky
#MedSky #IDSky
Reposted by Grace Macaulay
VASP phase 2b trial: No vaccine against Salmonella enterica serovar Paratyphi A is currently available. Research findings involving a candidate vaccine are summarized in a new Quick Take video. nej.md/43Gbmjc
#MedSky #IDSky
#MedSky #IDSky
November 2, 2025 at 5:02 PM
VASP phase 2b trial: No vaccine against Salmonella enterica serovar Paratyphi A is currently available. Research findings involving a candidate vaccine are summarized in a new Quick Take video. nej.md/43Gbmjc
#MedSky #IDSky
#MedSky #IDSky
Reposted by Grace Macaulay
In a trial in healthy U.K. adults who were challenged with S. Paratyphi A in a controlled human infection model, two doses of the candidate vaccine CVD 1902 led to protection against S. Paratyphi A infection. Full VASP phase 2b trial results and Research Summary: nej.md/3Lypfd5
#MedSky
#MedSky
November 5, 2025 at 2:03 PM
In a trial in healthy U.K. adults who were challenged with S. Paratyphi A in a controlled human infection model, two doses of the candidate vaccine CVD 1902 led to protection against S. Paratyphi A infection. Full VASP phase 2b trial results and Research Summary: nej.md/3Lypfd5
#MedSky
#MedSky
New paper out 📣 Final results from the COV006 study - Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years 🦠📊 @grace-li.bsky.social @ox.ac.uk @ovg.ox.ac.uk
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006)
Paediatric COVID-19 vaccination programmes were initiated in response to the coronavirus pandemic declared by the World Health Organisation (WHO) in 2…
www.sciencedirect.com
August 30, 2025 at 10:38 AM
New paper out 📣 Final results from the COV006 study - Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years 🦠📊 @grace-li.bsky.social @ox.ac.uk @ovg.ox.ac.uk
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Great to help host the London School of Paediatrics Research Evening this week — brilliant to see the research being done by trainees across London. Huge thanks to our speakers, attendees, and team. 🔬🩺✨
#londonschoolofpaediatrics #paediatricresearch
#londonschoolofpaediatrics #paediatricresearch
May 2, 2025 at 12:43 PM
Great to help host the London School of Paediatrics Research Evening this week — brilliant to see the research being done by trainees across London. Huge thanks to our speakers, attendees, and team. 🔬🩺✨
#londonschoolofpaediatrics #paediatricresearch
#londonschoolofpaediatrics #paediatricresearch
Happening next week - celebrating paediatric research being done by amazing trainees! ⬇️👏
Our next Paediatric Research Evening brought to you by the London School of Paediatrics🔬🌍🩺
If you’re a Paeds Trainee/Fellow/ACF and keen to attend, or present, sign-up via the link below or flick me a message! ⬇️
#paediatricresearch #childhealth
If you’re a Paeds Trainee/Fellow/ACF and keen to attend, or present, sign-up via the link below or flick me a message! ⬇️
#paediatricresearch #childhealth
April 23, 2025 at 9:05 AM
Happening next week - celebrating paediatric research being done by amazing trainees! ⬇️👏
Our next Paediatric Research Evening brought to you by the London School of Paediatrics🔬🌍🩺
If you’re a Paeds Trainee/Fellow/ACF and keen to attend, or present, sign-up via the link below or flick me a message! ⬇️
#paediatricresearch #childhealth
If you’re a Paeds Trainee/Fellow/ACF and keen to attend, or present, sign-up via the link below or flick me a message! ⬇️
#paediatricresearch #childhealth
April 3, 2025 at 6:23 AM
Our next Paediatric Research Evening brought to you by the London School of Paediatrics🔬🌍🩺
If you’re a Paeds Trainee/Fellow/ACF and keen to attend, or present, sign-up via the link below or flick me a message! ⬇️
#paediatricresearch #childhealth
If you’re a Paeds Trainee/Fellow/ACF and keen to attend, or present, sign-up via the link below or flick me a message! ⬇️
#paediatricresearch #childhealth
NEW SITE | The BiVISTA - Bivalent Vaccination against Salmonella Typhi and Paratyphi A study has begun recruiting in Hull.
For more information: ovg.ox.ac.uk/studies/bivi...
For more information: ovg.ox.ac.uk/studies/bivi...
February 17, 2025 at 11:31 AM
Reposted by Grace Macaulay
How can mesocosms help tackle grand ecological challenges in aquatic ecosystems? 🌊🌍
Check out our open-access Oikos Forum article, out today: 🔗 doi.org/10.1111/oik....
@oikosjournal.bsky.social
Check out our open-access Oikos Forum article, out today: 🔗 doi.org/10.1111/oik....
@oikosjournal.bsky.social
Addressing grand ecological challenges in aquatic ecosystems: how can mesocosms be used to advance solutions?
Rapid and drastic anthropogenic impacts are affecting global biogeochemical processes and driving biodiversity loss across Earth's ecosystems. In aquatic ecosystems, species distributions are shiftin...
doi.org
February 11, 2025 at 6:15 PM
How can mesocosms help tackle grand ecological challenges in aquatic ecosystems? 🌊🌍
Check out our open-access Oikos Forum article, out today: 🔗 doi.org/10.1111/oik....
@oikosjournal.bsky.social
Check out our open-access Oikos Forum article, out today: 🔗 doi.org/10.1111/oik....
@oikosjournal.bsky.social